Cherise Frazier
Neurology with Special Qualifications in Child Neurology · Atlanta, GANPI 1689833683
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,982 of the $8,953 with a category attached, or 78.0%. It is spread thinly across 37 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,198, 2.7 times the $828 reported in 2019.
Across 356 payments — averaging $25.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otter Pharmaceuticals, LLC$1K
- Supernus Pharmaceuticals, Inc.$1K
- Jazz Pharmaceuticals Inc.$1K
- UCB, Inc.$876
- Eisai Inc.$844
- Catalyst Pharmaceuticals, Inc.$574
- plus $3K from 31 others
Across 1 payment — averaging $4000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Supernus Pharmaceuticals, Inc.$4K
What the payments were for
- Consulting fees$1,93822%
- Food & beverage$6,98278%
- Education$330%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,953 in reported general payments places this provider in the 80th percentile of 41 neurology with special qualifications in child neurology providers in Georgia.
See all neurology with special qualifications in child neurology providers in Georgia →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rufinamide | 15 | $8,191 |
| Clonazepam | 13 | $240 |
Paid to pharmacies, not to this prescriber.
Other neurology with special qualifications in child neurology in Atlanta
- Chaouki KhouryAtlanta$978K
- Han PhanAtlanta$44K
- Raymond ChengAtlanta$40K
- Sonam BhallaAtlanta$23K
- Howard SchubAtlanta$7K
- Ton de GrauwAtlanta$4K
- Jamika Hallman-CooperAtlanta$2K
- Moira BlackAtlanta$1K
- Jenny LinAtlanta$1K
- Kishore VedalaAtlanta$733
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.